drugset
drugset / Trial / NCT03432923

A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.

NCT03432923 ↗

Phase 3 Completed 260 enrolled McNeil AB Janssen Pharmaceutica N.V., Belgium · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A multi-center, double-blind, randomized, parallel-group, placebo-controlled study to determine the efficacy and safety of a benzocaine lozenge for symptomatic treatment of sore throat caused by acute upper respiratory tract infection in adults.

Timeline

Start
2018-02-02
Primary completion
2018-04-21
Completion
2018-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzocaine Small molecule 8 mg Oral

Indications

pharyngitis